Introducing vasomotor symptoms
‘VMS breakthroughs: Empowering HCPs with expertise and advanced therapeutic approaches’ is a four-article series beginning with:
- An introduction to the burdens of vasomotor symptoms (VMS) focusing on the adverse impacts of VMS on women’s quality of life, including socioeconomic impact
- An overview of the mental health impacts of VMS and the treatment options available
Coming soon to the ‘VMS breakthroughs’ series:
- A closer look at the mechanisms underlying VMS and how improved understanding of these mechanisms has facilitated the development of non-hormonal treatments
- The latest on the management of VMS and how recent advances are addressing unmet needs
In addition to further articles, get an expert perspective on VMS impact and management with Dr Juliana Kling (Mayo Clinic, Scottsdale, Arizona, USA).
Meet the expert
Dr Juliana (Jewel) Kling
Dr Kling is a Professor of Medicine, Chair of the Division of Women’s Health Internal Medicine, Assistant Director of the Mayo Clinic Women’s Health Center, and Dean of the Mayo Clinic Alix School of Medicine AZ campus at the Mayo Clinic in Scottsdale, Arizona, USA. Her clinical and research interests are in menopause, sexual health, LGBT care, and education, as well as in efforts to expand the discipline of sex- and gender-specific medicine.
Disclosures: AiCME, Contemporary OB/GYN, Elsevier, Evolve Medical Education, Let’s Talk Menopause, and Paradise Valley Country Club.
Understanding the burden of VMS on women's lives
The burden of vasomotor symptoms can impact the lives of women in various ways and take a significant toll on quality of life.
Mental health implications of VMS
Vasomotor symptoms have significant and negative impacts on the mental wellbeing of menopausal women.